Clinical Nurse Specialist Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Amy Wolford

Clinical Nurse Specialist, Psychiatric/Mental Health Houston, TX Clinical Nurse Specialist

NPI 1013033018 CMS profile 10505539

14340 Torrey Chase Blvd, Suite 160, Houston, TX 77014

Open in the dashboard

General payments

$9,069

585 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amy Wolford of Houston, TX is reported in the CMS Open Payments database as having received $9,069 across 585 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Clinical Nurse Specialist, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,605 158
2024 General $1,947 127
2023 General $1,628 112
2022 General $1,106 69
2021 General $1,782 119

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amy Wolford
  • Clinical Nurse Specialist, Psychiatric/Mental Health median
  • Middle half of Clinical Nurse Specialist, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Amy Wolford were reported at $2,605. Among 300 Clinical Nurse Specialist, Psychiatric/Mental Health profiles paid that year, the median was $245 and the middle half received between $78 and $929.

Show as a table
Year Amy Wolford Clinical Nurse Specialist, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,782 $153 $44–$540 $132
2022 $1,106 $207 $60–$748 $149
2023 $1,628 $197 $55–$898 $160
2024 $1,947 $189 $49–$804 $164
2025 $2,605 $245 $78–$929 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. ITI, Inc. $1,520 88 payments
  2. Otsuka America Pharmaceutical, Inc. $961 81 payments
  3. AbbVie, Inc. $911 65 payments
  4. Teva Pharmaceuticals USA, Inc. $769 54 payments
  5. Neurocrine Biosciences, Inc. $590 38 payments
  6. Alkermes, Inc. $534 37 payments
  7. Axsome Therapeutics, Inc. $397 21 payments
  8. Corium, Inc. $343 27 payments
  9. Janssen Pharmaceuticals, Inc $340 21 payments
  10. Almatica Pharma LLC $308 18 payments
  11. Other $2,397 135 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $9,011 582 payments
  2. Education $58 3 payments
Products named General payments · program years 2021–2025
  1. CAPLYTA $1,232 68 payments
  2. VRAYLAR $635 51 payments
  3. INGREZZA $575 37 payments
  4. ARISTADA Cns $503 35 payments
  5. ARISTADA Cns $503 35 payments
  6. LYBALVI $490 35 payments
  7. ARISTADA Cns $478 34 payments
  8. ARISTADA Cns $478 34 payments
  9. ABILIFY MAINTENA $436 49 payments
  10. REXULTI $429 50 payments
  11. Other $6,852 413 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

585 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Nurse Specialist, Psychiatric/Mental Health in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record